Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Seeking Alpha Contributor's investment thesis on Journey Medical ($DERM) | Buyside Digest

All Pitches

$DERMNASDAQJourney Medical

BULL

Seeking Alpha Contributor—DERM

Seeking Alpha

Published August 20, 2026

$7.53USD

-4.2% vs last month

$6.81Pitched

+10.6% since pitch

Market Cap$178.4M

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From Seeking Alpha

Journey Medical Corporation, despite a challenging year-to-date performance, shows promising signs of recovery and growth. The company's Q2...

— Seeking Alpha Contributor

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $DERM

Other pitches on $DERM

Other investors who've written on Journey Medical

Minot Light Capital PartnersBULL

Pitched Jan 1, 2025

Journey Medical represents a compelling specialty pharmaceutical play backed by its recent FDA approval of Emrosi for treating Rosacea. Emrosi has shown...

View all $DERM pitches →